Theresa Niedermeier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Theresa Niedermeier has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Jochen Herms
Institute of Neuropathology, LMU Medizin, Ludwig-Maximilians-Universität (LMU) München, Munich, Germany
2 shared publications - Lars Paeger
German Center for Neurodegenerative Diseases (DZNE), Munich
2 shared publications - Boris-Stephan Rauchmann
Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany
1 shared publication - Carolin Kurz
Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany
1 shared publication Carolin Meyer
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
1 shared publicationDanilo Prtvar
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
1 shared publication
Latest Publications
- Open Access
- 15 October 2025
- Published by Springer Nature in Research Square
Neuron subtypes have distinct mitochondrial transport in axons and vulnerability to tau in vivo
Mitochondria are the primary energy producing organelles in eukaryotic cells. Their location is tied to the cell compartment’s energy requirement. Whether mitochondria are actively transported and retain their motility in neuronal axons of adult animals remains debated. Here we show not only a higher fraction of motile axonal mitochondria than currently described, but also marked differences in transport dynamics across neuronal subtypes. We further show that aggregated tau in the Locus Coeruleus (LC), an early pathological hallmark of Alzheimer’s disease, impairs mitochondrial transport along axons, an effect absent in cortical inhibitory and excitatory neurons. Collectively, we demonstrate the abundant and diverse motility of neuronal mitochondria in vivo, and reveal a correlate of LC vulnerability to tau proteinopathy in neurodegenerative diseases.
- 15 October 2025
- Published by Springer Nature in Research Square
Open AccessNeuron subtypes have distinct mitochondrial transport in axons and vulnerability to tau in vivo
Mitochondria are the primary energy producing organelles in eukaryotic cells. Their location is tied to the cell compartment’s energy requirement. Whether mitochondria are actively transported and retain their motility in neuronal axons of adult animals remains debated. Here we show not only a higher fraction of motile axonal mitochondria than currently described, but also marked differences in transport dynamics across neuronal subtypes. We further show that aggregated tau in the Locus Coeruleus (LC), an early pathological hallmark of Alzheimer’s disease, impairs mitochondrial transport along axons, an effect absent in cortical inhibitory and excitatory neurons. Collectively, we demonstrate the abundant and diverse motility of neuronal mitochondria in vivo, and reveal a correlate of LC vulnerability to tau proteinopathy in neurodegenerative diseases.
- Open Access
- 8 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 7338
Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer’s disease
Alzheimer’s disease (AD) often begins with non-cognitive symptoms such as olfactory deficits, which can predict later cognitive decline, though the mechanisms remain unclear. Pathologically, the brainstem locus coeruleus (LC), the main source of the neurotransmitter noradrenalin (NA) modulating olfactory information processing is affected early. Here we show early and distinct loss of noradrenergic input to the olfactory bulb (OB) coinciding with impaired olfaction in an AD mouse model, before appearance of amyloid plaques. Mechanistically, OB microglia recognize and phagocytose LC axons. Reducing phagocytosis genetically preserves LC axons and olfaction. Prodromal AD patients display elevated TSPO-PET signals in the OB, similarly to App NL-G-F mice. We further confirm early LC axon degeneration in post-mortem OBs in patients with early AD. Our findings reveal a mechanism linking early LC damage to hyposmia in AD, suggesting olfactory testing and neurocircuit imaging for early diagnosis and enable timely therapeutic intervention for Alzheimer’s disease.
- 8 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 7338
Open AccessEarly Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer’s disease
Alzheimer’s disease (AD) often begins with non-cognitive symptoms such as olfactory deficits, which can predict later cognitive decline, though the mechanisms remain unclear. Pathologically, the brainstem locus coeruleus (LC), the main source of the neurotransmitter noradrenalin (NA) modulating olfactory information processing is affected early. Here we show early and distinct loss of noradrenergic input to the olfactory bulb (OB) coinciding with impaired olfaction in an AD mouse model, before appearance of amyloid plaques. Mechanistically, OB microglia recognize and phagocytose LC axons. Reducing phagocytosis genetically preserves LC axons and olfaction. Prodromal AD patients display elevated TSPO-PET signals in the OB, similarly to App NL-G-F mice. We further confirm early LC axon degeneration in post-mortem OBs in patients with early AD. Our findings reveal a mechanism linking early LC damage to hyposmia in AD, suggesting olfactory testing and neurocircuit imaging for early diagnosis and enable timely therapeutic intervention for Alzheimer’s disease.